Citations (175)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (23)
Amit Talukdar, Priya Maddhesiya, Nima Dondu Namsa & Robin Doley. (2023) Snake venom toxins targeting the central nervous system. Toxin Reviews 42:1, pages 382-406.
Read now
Read now
Yadollah Omidi, Nazanin Kianinejad, Young Kwon & Hossein Omidian. (2021) Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier. Expert Review of Clinical Pharmacology 14:3, pages 357-381.
Read now
Read now
Smrithi Padmakumar, Maie S. Taha, Ekta Kadakia, Benjamin S. Bleier & Mansoor M. Amiji. (2020) Delivery of neurotrophic factors in the treatment of age-related chronic neurodegenerative diseases. Expert Opinion on Drug Delivery 17:3, pages 323-340.
Read now
Read now
Giovanni Tosi, J. T. Duskey & Jörg Kreuter. (2020) Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier. Expert Opinion on Drug Delivery 17:1, pages 23-32.
Read now
Read now
Govindarajan Karthivashan, Palanivel Ganesan, Shin-Young Park, Joon-Soo Kim & Dong-Kug Choi. (2018) Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease. Drug Delivery 25:1, pages 307-320.
Read now
Read now
Tony Bewersdorff, Jonathan Vonnemann, Asiye Kanik, Rainer Haag & Andrea Haase. (2017) The influence of surface charge on serum protein interaction and cellular uptake: studies with dendritic polyglycerols and dendritic polyglycerol-coated gold nanoparticles. International Journal of Nanomedicine 12, pages 2001-2019.
Read now
Read now
Ayesha Khan, Anne Corbett & Clive Ballard. (2017) Emerging treatments for Alzheimer’s disease for non-amyloid and non-tau targets. Expert Review of Neurotherapeutics 17:7, pages 683-695.
Read now
Read now
Igor Khalin, Renad Alyautdin, Tin Wui Wong, Justin Gnanou, Ganna Kocherga & Jörg Kreuter. (2016) Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury. Drug Delivery 23:9, pages 3520-3528.
Read now
Read now
Andrew M. Hall, Ruth Hemmer, Robert Spaulding, Hanna N. Wetzel, Joseph Curcio, Bernhard A. Sabel, Petra Henrich-Noack, Sarah Pixley, Tracy Hopkins, Richard L. Boyce, Patrick J. Schultheis & Kristi L. Haik. (2016) Cytotoxicity and apoptotic gene expression in an in vitro model of the blood–brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles. Journal of Drug Targeting 24:7, pages 635-644.
Read now
Read now
Yahya E. Choonara, Pradeep Kumar, Girish Modi & Viness Pillay. (2016) Improving drug delivery technology for treating neurodegenerative diseases. Expert Opinion on Drug Delivery 13:7, pages 1029-1043.
Read now
Read now
Andreas M Grabrucker, Barbara Ruozi, Daniela Belletti, Francesca Pederzoli, Flavio Forni, Maria Angela Vandelli & Giovanni Tosi. (2016) Nanoparticle transport across the blood brain barrier. Tissue Barriers 4:1.
Read now
Read now
Shiya Gao, Yurui Xu, Sajid Asghar, Minglei Chen, Lang Zou, Sulieman Eltayeb, Meirong Huo, Qineng Ping & Yanyu Xiao. (2015) Polybutylcyanoacrylate nanocarriers as promising targeted drug delivery systems. Journal of Drug Targeting 23:6, pages 481-496.
Read now
Read now
Renad Alyautdin, Igor Khalin, Mohd Ismail Nafeeza, Muhammad Huzaimi Haron & Dmitry Kuznetsov. (2014) Nanoscale drug delivery systems and the blood–brain barrier. International Journal of Nanomedicine 9, pages 795-811.
Read now
Read now
Sumeet Sood, Kunal Jain & K. Gowthamarajan. (2014) Intranasal therapeutic strategies for management of Alzheimer’s disease. Journal of Drug Targeting 22:4, pages 279-294.
Read now
Read now
Bindu Balakrishnan, Elizabeth Nance, Michael V Johnston, Rangaramanujam Kannan & Sujatha Kannan. (2013) Nanomedicine in cerebral palsy. International Journal of Nanomedicine 8, pages 4183-4195.
Read now
Read now
Antony Deva Punitha & Anand Kumar Srivastava. (2013) CNS drug targeting: have we travelled in right path?. Journal of Drug Targeting 21:9, pages 787-800.
Read now
Read now
Kalpana Nagpal, Shailendra Kumar Singh & Dina Nath Mishra. (2013) Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB. Expert Opinion on Drug Delivery 10:7, pages 927-955.
Read now
Read now
Jörg Kreuter. (2013) Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB). Journal of Microencapsulation 30:1, pages 49-54.
Read now
Read now
Anne Corbett & Clive Ballard. (2012) New and emerging treatments for Alzheimer's disease. Expert Opinion on Emerging Drugs 17:2, pages 147-156.
Read now
Read now
Anne Corbett, Jessica Smith & Clive Ballard. (2012) New and emerging treatments for Alzheimer’s disease. Expert Review of Neurotherapeutics 12:5, pages 535-543.
Read now
Read now
Shadabul Haque, Shadab Md, Md. Intekhab Alam, Jasjeet K. Sahni, Javed Ali & Sanjula Baboota. (2012) Nanostructure-based drug delivery systems for brain targeting. Drug Development and Industrial Pharmacy 38:4, pages 387-411.
Read now
Read now
Anja Zensi, David Begley, Charles Pontikis, Celine Legros, Larisa Mihoreanu, Claudia Büchel & Jörg Kreuter. (2010) Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain. Journal of Drug Targeting 18:10, pages 842-848.
Read now
Read now
Rama Mallipeddi & Lisa Cencia Rohan. (2010) Nanoparticle-based vaginal drug delivery systems for HIV prevention. Expert Opinion on Drug Delivery 7:1, pages 37-48.
Read now
Read now
Articles from other publishers (152)
Shanshan Guo & Chun-Xia Yi. (2023) Cell type-targeting nanoparticles in treating central nervous system diseases: Challenges and hopes. Nanotechnology Reviews 12:1.
Crossref
Crossref
Mahmoud G. El Baassiri, Laura Dosh, Hanine Haidar, Alice Gerges, Silma Baassiri, Angelo Leone, Francesca Rappa & Abdo Jurjus. (2023) Nerve growth factor and burn wound healing: Update of molecular interactions with skin cells. Burns 49:5, pages 989-1002.
Crossref
Crossref
Marina Placci, Marina I. Giannotti & Silvia Muro. (2023) Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders. Advanced Drug Delivery Reviews 197, pages 114683.
Crossref
Crossref
Parinaz Sabourian, Masoud Frounchi, Sahar Kiani, Shohreh Mashayekhan, Masoumeh Zarei Kheirabadi, Yasaman Heydari & Seyed Sajad Ashraf. (2023) Targeting reactive astrocytes by pH-responsive ligand-bonded polymeric nanoparticles in spinal cord injury. Drug Delivery and Translational Research 13:6, pages 1842-1855.
Crossref
Crossref
Ranjana Bhandari, Jyoti K Paliwal & Anurag Kuhad. (2023) Enhanced Bioavailability and Higher Uptake of Brain-Targeted Surface
Engineered Delivery System of Naringenin developed as a Therapeutic for
Autism Spectrum Disorder. Current Drug Delivery 20:2, pages 158-182.
Crossref
Crossref
Zi-Hua Guo, Saadullah Khattak, Mohd Ahmar Rauf, Mohammad Azam Ansari, Mohammad N. Alomary, Sufyan Razak, Chang-Yong Yang, Dong-Dong Wu & Xin-Ying Ji. (2023) Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders. Molecules 28:3, pages 1283.
Crossref
Crossref
Aziz Unnisa, NigelH Greig & MohammadAmjad Kamal. (2023) Nanotechnology-based gene therapy as a credible tool in the treatment of Alzheimer’s disease. Neural Regeneration Research 18:10, pages 2127.
Crossref
Crossref
Kunjbihari Sulakhiya, Anglina Kisku, Rishi Paliwal, Deepak K Gupta, Yashraj Yadav, Ajay Pal & Suneel Kumar. 2023. Nanotechnology for Drug Delivery and Pharmaceuticals. Nanotechnology for Drug Delivery and Pharmaceuticals
131
163
.
Naumih M. Noah & Peter M. Ndangili. 2023. Polymeric Nanosystems. Polymeric Nanosystems
723
759
.
Nicola Paccione, Mahdieh Rahmani, Emilia Barcia & Sofía Negro. (2022) Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems. Pharmaceutics 15:1, pages 13.
Crossref
Crossref
Li Li, Rendong He, Haili Yan, Zhengwei Leng, Shuang Zhu & Zhanjun Gu. (2022) Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis. Nano Today 47, pages 101654.
Crossref
Crossref
Ramya Rajan, Kaushik Pal, D Jayadev, Jitha S Jayan, Aathira U, Saritha Appukuttan, Fernando Gomes de Souza, Kuruvilla Joseph & Saran S Kumar. (2022) Polymeric Nanoparticles in Hybrid Catalytic Processing and Drug Delivery System. Topics in Catalysis 65:19-20, pages 1860-1884.
Crossref
Crossref
Kshama A. Doshi. 2022. Targeted Drug Delivery. Targeted Drug Delivery
1
19
.
Panoraia I. Siafaka, Mehmet Evren Okur, Pelin Dilsiz Erim, Emre Şefik Çağlar, Emre Özgenç, Evren Gündoğdu, Rabia Edibe Parlar Köprülü, Ioannis D. Karantas & Neslihan Üstündağ Okur. (2022) Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today?. Pharmaceutics 14:11, pages 2425.
Crossref
Crossref
Shampa Ghosh, Bhuvi Sachdeva, Punya Sachdeva, Vishal Chaudhary, Gokana Mohana Rani & Jitendra Kumar Sinha. (2022) Graphene quantum dots as a potential diagnostic and therapeutic tool for the management of Alzheimer’s disease. Carbon Letters 32:6, pages 1381-1394.
Crossref
Crossref
Miguel Pinto, Vera Silva, Sandra Barreiro, Renata Silva, Fernando Remião, Fernanda Borges & Carlos Fernandes. (2022) Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform. Ageing Research Reviews 79, pages 101658.
Crossref
Crossref
Simona Martano, Valeria De Matteis, Mariafrancesca Cascione & Rosaria Rinaldi. (2022) Inorganic Nanomaterials versus Polymer-Based Nanoparticles for Overcoming Neurodegeneration. Nanomaterials 12:14, pages 2337.
Crossref
Crossref
Mehdi Farhoudi, Saeed Sadigh-Eteghad, Javad Mahmoudi, Afsaneh Farjami, Mohammad Mahmoudian & Sara Salatin. (2022) The Therapeutic Benefits of Intravenously Administrated Nanoparticles in Stroke
and Age-related Neurodegenerative Diseases. Current Pharmaceutical Design 28:24, pages 1985-2000.
Crossref
Crossref
Jingyi An, Ling Zhao, Ranran Duan, Ke Sun, Wenxin Lu, Jiali Yang, Yan Liang, Junjie Liu, Zhenzhong Zhang, Li Li & Jinjin Shi. (2022) Potential nanotherapeutic strategies for perioperative stroke. CNS Neuroscience & Therapeutics 28:4, pages 510-520.
Crossref
Crossref
Yu Wang, Feng Jia & Yong Lin. (2022) Poly(butyl cyanoacrylate) nanoparticles-delivered β-nerve growth factor promotes the neurite outgrowth and reduces the mortality in the rat after traumatic brain injury. Nanotechnology 33:13, pages 135101.
Crossref
Crossref
Priyanka Saha, Subhankar Bose, Md Noushad Javed & Amit K. Srivastava. 2022. Advances in Nanotechnology-Based Drug Delivery Systems. Advances in Nanotechnology-Based Drug Delivery Systems
133
154
.
Rewati Raman Ujjwal, Sandeep Kr Maharana, Mayank Handa & S.T.V. Sai Krishna. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
99
117
.
Pallav Namdeo, Jinu Mathew & Ashish Garg. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
223
242
.
Ashni Arun, Pratyusha Malrautu, Anindita Laha, Hongrong Luo & Seeram Ramakrishna. (2021) Collagen Nanoparticles in Drug Delivery Systems and Tissue Engineering. Applied Sciences 11:23, pages 11369.
Crossref
Crossref
Jyotsna Shankar, Geetha K.M & Barnabas Wilson. (2021) Potential applications of nanomedicine for treating Parkinson's disease. Journal of Drug Delivery Science and Technology 66, pages 102793.
Crossref
Crossref
Quan-You Li, Jung-Hwan Lee, Hae-Won Kim & Guang-Zhen Jin. (2021) Research Models of the Nanoparticle-Mediated Drug Delivery across the Blood–Brain Barrier. Tissue Engineering and Regenerative Medicine 18:6, pages 917-930.
Crossref
Crossref
Tivadar Feczkó. (2021) Polymeric nanotherapeutics acting at special regions of body. Journal of Drug Delivery Science and Technology 64, pages 102597.
Crossref
Crossref
Giuseppe Alastra, Luigi Aloe, Vito Antonio Baldassarro, Laura Calzà, Maura Cescatti, Jason Thomas Duskey, Maria Letizia Focarete, Daria Giacomini, Luciana Giardino, Valentina Giraldi, Luca Lorenzini, Marzia Moretti, Irene Parmeggiani, Michele Sannia & Giovanni Tosi. (2021) Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application?. Frontiers in Neuroscience 15.
Crossref
Crossref
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Thi Kim Oanh Nguyen, Tuong Kha Vo & Van Giau Vo. (2021) Advances in developing therapeutic strategies for Alzheimer's disease. Biomedicine & Pharmacotherapy 139, pages 111623.
Crossref
Crossref
Olesja Bondarenko & Mart Saarma. (2021) Neurotrophic Factors in Parkinson’s Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain. Frontiers in Cellular Neuroscience 15.
Crossref
Crossref
Weisen Zhang, Ami Mehta, Ziqiu Tong, Lars Esser & Nicolas H. Voelcker. (2021) Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges. Advanced Science 8:10, pages 2003937.
Crossref
Crossref
Fabien Gosselet, Rodrigo Azevedo Loiola, Anna Roig, Anna Rosell & Maxime Culot. (2021) Central nervous system delivery of molecules across the blood-brain barrier. Neurochemistry International 144, pages 104952.
Crossref
Crossref
A. Zaghmi, J. Drouin-Ouellet, D. Brambilla & M.A. Gauthier. (2021) Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies. Biomaterials 269, pages 120461.
Crossref
Crossref
Sreekanth Sreekumaran, Anitha Radhakrishnan & Sanju P. Joy. 2021. Regenerated Organs. Regenerated Organs
277
289
.
Saikat Ghosh, Pooja Mishra, Amit Dabke, Anjali Pathak, Subhas Bhowmick & Ambikanandan Misra. 2021. Applications of Polymers in Drug Delivery. Applications of Polymers in Drug Delivery
393
421
.
Saba Sohail & Fakhar-Ud-Din. 2021. Cancer Nanotheranostics. Cancer Nanotheranostics
117
154
.
Sumonto Mitra, Ruchi Gera, Bengt Linderoth, Göran Lind, Lars Wahlberg, Per Almqvist, Homira Behbahani & Maria Eriksdotter. 2021. Recent Advances in NGF and Related Molecules. Recent Advances in NGF and Related Molecules
167
191
.
Thuy Trang Nguyen, Tuong Kha Vo & Giau Van Vo. 2021. Reviews on New Drug Targets in Age-Related Disorders. Reviews on New Drug Targets in Age-Related Disorders
183
198
.
Natascha Hartl, Friederike Adams & Olivia M. Merkel. (2020) From Adsorption to Covalent Bonding: Apolipoprotein E Functionalization of Polymeric Nanoparticles for Drug Delivery Across the Blood–Brain Barrier. Advanced Therapeutics 4:1, pages 2000092.
Crossref
Crossref
Roma Ghai, Kandasamy Nagarajan, Meenakshi Arora, Parul Grover, Nazakat Ali & Garima Kapoor. (2020) Current Strategies and Novel Drug Approaches for Alzheimer Disease. CNS & Neurological Disorders - Drug Targets 19:9, pages 676-690.
Crossref
Crossref
Suresh Thangudu, Fong-Yu Cheng & Chia-Hao Su. (2020) Advancements in the Blood–Brain Barrier Penetrating Nanoplatforms for Brain Related Disease Diagnostics and Therapeutic Applications. Polymers 12:12, pages 3055.
Crossref
Crossref
Nkiruka Ibeanu, Raphael Egbu, Lesley Onyekuru, Hoda Javaheri, Peng Tee Khaw, Gareth R. Williams, Steve Brocchini & Sahar Awwad. (2020) Injectables and Depots to Prolong Drug Action of Proteins and Peptides. Pharmaceutics 12:10, pages 999.
Crossref
Crossref
Barnabas Wilson & Kannoth Mukundan Geetha. (2020) Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease. Journal of Controlled Release 325, pages 25-37.
Crossref
Crossref
Tao Ming Sim, Dinesh Tarini, S. Thameem Dheen, Boon Huat Bay & Dinesh Kumar Srinivasan. (2020) Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders. International Journal of Molecular Sciences 21:17, pages 6070.
Crossref
Crossref
Gülcem Altinoglu & Terin Adali. (2020) Alzheimer’s Disease Targeted Nano-Based Drug Delivery Systems. Current Drug Targets 21:7, pages 628-646.
Crossref
Crossref
Anmol Dogra, R.S. Narang & Jasjeet K. Narang. (2020) Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer’s Disease. Current Pharmaceutical Design 26:19, pages 2257-2279.
Crossref
Crossref
Saba Naqvi, Archna Panghal & S. J. S. Flora. (2020) Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs. Frontiers in Neuroscience 14.
Crossref
Crossref
Yingqian Xu, Lijia Wei & Hui Wang. (2020) Progress and perspectives on nanoplatforms for drug delivery to the brain. Journal of Drug Delivery Science and Technology 57, pages 101636.
Crossref
Crossref
Morteza Rabiei, Soheila Kashanian, Seyedeh S. Samavati, Shahriar Jamasb & Steven J.P. McInnes. (2020) Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review. Current Pharmaceutical Biotechnology 21:5, pages 374-383.
Crossref
Crossref
Mahira Zeeshan, Mahwash Mukhtar, Qurat Ul Ain, Salman Khan & Hussain Ali. 2020. Pharmaceutical Formulation Design - Recent Practices. Pharmaceutical Formulation Design - Recent Practices.
Zhanwen Wang, Ying Cheng, Deqiang Zhao, Artem Pliss, Jun Liu & Ping Luan. (2020) Synergic treatment of Alzheimer’s disease with brain targeted nanoparticles incorporating NgR-siRNA and brain derived neurotrophic factor. Smart Materials in Medicine 1, pages 125-130.
Crossref
Crossref
Fatemeh Khatami. 2020. Neural Regenerative Nanomedicine. Neural Regenerative Nanomedicine
285
297
.
Serda Kecel-Gunduz, Bilge Bicak & Aysen E. Ozel. 2020. Neural Regenerative Nanomedicine. Neural Regenerative Nanomedicine
89
122
.
Ramchander Merugu. 2020. Nanomaterials in Biofuels Research. Nanomaterials in Biofuels Research
75
113
.
Akhand Pratap Singh, Arpan Biswas, Aparna Shukla & Pralay Maiti. (2019) Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal Transduction and Targeted Therapy 4:1.
Crossref
Crossref
Marissa E. Wechsler, Julia E. Vela Ramirez & Nicholas A. Peppas. (2019)
110th Anniversary
: Nanoparticle Mediated Drug Delivery for the Treatment of Alzheimer’s Disease: Crossing the Blood–Brain Barrier
. Industrial & Engineering Chemistry Research 58:33, pages 15079-15087.
Crossref
Crossref
Juhi Samal, Ana Lucia Rebelo & Abhay Pandit. (2019) A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders. Advanced Drug Delivery Reviews 148, pages 68-145.
Crossref
Crossref
Miguel Pinto, Carlos Fernandes, Eva Martins, Renata Silva, Sofia Benfeito, Fernando Cagide, Ricardo F. Mendes, Filipe A. Almeida Paz, Jorge Garrido, Fernando Remião & Fernanda Borges. (2019) Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles. Pharmaceutics 11:7, pages 331.
Crossref
Crossref
Gifty M. Jojo & Gowthamarajan Kuppusamy. (2019) Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer’s disease. Journal of Clinical Pharmacy and Therapeutics 44:3, pages 337-348.
Crossref
Crossref
Luca Bors & Franciska Erdő. (2019) Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery. Scientia Pharmaceutica 87:1, pages 6.
Crossref
Crossref
Abhishek Mukherjee, Sibani Sarkar, Sayantan Jana, Snehasikta Swarnakar & Nirmalendu Das. (2019) Neuro-protective role of nanocapsulated curcumin against cerebral ischemia-reperfusion induced oxidative injury. Brain Research 1704, pages 164-173.
Crossref
Crossref
М. Ю. Капитонова, Р. Н. Аляутдин, Р. В. А. Л. Ван Шазли, М. Н. К. Нор-Ашикин, А. Ахмад, С. Норита & С. С. Дыдыкин. (2018) Применение полимерных коллоидных носителей для таргетной доставки мозгового трофического фактора через гемато-энцефалический барьер при экспериментальном. Вестник Российского Государственного медицинского университета:6, pages 116-122.
Crossref
Crossref
M.Yu. Kapitonova, R.N. Alyautdin, R.W.A.L. Wan-Syazli, M.N.K. Nor-Ashikin, A. Аhmad, S. Norita & S.S. Dydykin. (2018) Application of nanoscale polymer colloid carriers for targeted delivery of the brain-derived neurotrophic factor through the blood-brain barrier in experimental parkinsonism. Bulletin of Russian State Medical University:6, pages 107-112.
Crossref
Crossref
Martin Hsiu-Chu Lin, Chiu-Yen Chung, Kuo-Tai Chen, Jih-Chao Yeh, Tsong-Hai Lee, Ming-Hsueh Lee, I-Neng Lee, Wei-Chao Huang & Jen-Tsung Yang. (2019) Comparison between Polybutylcyanoacrylate Nanoparticles with Either Surface-Adsorbed or Encapsulated Brain-Derived Neurotrophic Factor on the Neural Differentiation of iPSCs. International Journal of Molecular Sciences 20:1, pages 182.
Crossref
Crossref
Tivadar Feczkó, Albrecht Piiper, Saema Ansar, Frank W. Blixt, Mukul Ashtikar, Susanne Schiffmann, Thomas Ulshöfer, Michael J. Parnham, Yifat Harel, Liron Limor Israel, Jean-Paul Lellouche & Matthias G. Wacker. (2019) Stimulating brain recovery after stroke using theranostic albumin nanocarriers loaded with nerve growth factor in combination therapy. Journal of Controlled Release 293, pages 63-72.
Crossref
Crossref
José Vicente Lafuente, Catalina Requejo & Luisa Ugedo. 2019. Nanoneuroprotection and Nanoneurotoxicology. Nanoneuroprotection and Nanoneurotoxicology
263
279
.
Yu Zhao, Chunxiong Zheng & Yang Liu. 2019. Nanomedicine in Brain Diseases. Nanomedicine in Brain Diseases
233
267
.
Yang Du, Shuying Wang, Fangyuan Li & Daishun Ling. 2019. Nanomedicine in Brain Diseases. Nanomedicine in Brain Diseases
83
114
.
Libing Fu, Roger Chung & Bingyang Shi. 2019. Theranostics. Theranostics
263
282
.
Khwaja Salahuddin Siddiqi, Azamal Husen, Sayed Sartaj Sohrab & Mensur Osman Yassin. (2018) Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease Management. Nanoscale Research Letters 13:1.
Crossref
Crossref
Ki-Taek Kim, Han Sol Lee, Jeong-Jun Lee, Eui Kyun Park, Bong-Seon Lee, Jae-Young Lee & Jong-Sup Bae. (2018) Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood–brain barrier. Future Medicinal Chemistry 10:22, pages 2659-2674.
Crossref
Crossref
Weiyuan Zhang, Wenyue Wang, David X Yu, Zhicheng Xiao & Zhiyong He. (2018) Application of nanodiagnostics and nanotherapy to CNS diseases. Nanomedicine 13:18, pages 2341-2371.
Crossref
Crossref
Débora Braga Vieira & Lionel Fernel Gamarra. 2018. Molecular Insight of Drug Design. Molecular Insight of Drug Design.
E. Mazzio, R. Badisa, S. Eyunni, S. Ablordeppey, B. George & K. F. A. Soliman. (2018)
Bioactivity-Guided Isolation of Neuritogenic Factor from the Seeds of the Gac Plant (
Momordica cochinchinensis
)
. Evidence-Based Complementary and Alternative Medicine 2018, pages 1-11.
Crossref
Crossref
Young Shin Kim, Muhammad Gulfam & Tao L. Lowe. (2018)
Thermoresponsive-
co
-Biodegradable Linear–Dendritic Nanoparticles for Sustained Release of Nerve Growth Factor To Promote Neurite Outgrowth
. Molecular Pharmaceutics 15:4, pages 1467-1475.
Crossref
Crossref
Nadeschda Schmidt, Jennifer Schulze, Dawid P. Warwas, Nina Ehlert, Thomas Lenarz, Athanasia Warnecke & Peter Behrens. (2018) Long-term delivery of brain-derived neurotrophic factor (BDNF) from nanoporous silica nanoparticles improves the survival of spiral ganglion neurons in vitro. PLOS ONE 13:3, pages e0194778.
Crossref
Crossref
Chunsheng He, Jason Li, Ping Cai, Taksim Ahmed, Jeffrey T. Henderson, Warren D. Foltz, Reina Bendayan, Andrew Michael Rauth & Xiao Yu Wu. (2018) Two-Step Targeted Hybrid Nanoconstructs Increase Brain Penetration and Efficacy of the Therapeutic Antibody Trastuzumab against Brain Metastasis of HER2-Positive Breast Cancer. Advanced Functional Materials 28:9, pages 1705668.
Crossref
Crossref
Buket Ucar & Christian Humpel. (2018) Collagen for brain repair: therapeutic perspectives. Neural Regeneration Research 13:4, pages 595.
Crossref
Crossref
M.J. Santander-Ortega, M. Plaza-Oliver, V. Rodríguez-Robledo, L. Castro-Vázquez, N. Villaseca-González, J. González-Fuentes, P. Marcos, M.M. Arroyo-Jiménez & M.V. Lozano. (2017) Colloids for drug delivery to the brain. Journal of Drug Delivery Science and Technology 42, pages 193-206.
Crossref
Crossref
Yang Hu, Jaap Rip, Pieter J. Gaillard, Elizabeth C.M. de Lange & Margareta Hammarlund-Udenaes. (2017) The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study. Journal of Pharmaceutical Sciences 106:9, pages 2606-2613.
Crossref
Crossref
Parichehr Hassanzadeh, Fatemeh Atyabi & Rassoul Dinarvand. (2017) Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders. Life Sciences 182, pages 93-103.
Crossref
Crossref
Ashutosh Kumar, Vikas Pareek, Muneeb A. Faiq, Pavan Kumar, Khursheed Raza, Pranav Prasoon, Subrahamanyam Dantham & Sankat Mochan. (2017) Regulatory role of NGFs in neurocognitive functions. Reviews in the Neurosciences 28:6, pages 649-673.
Crossref
Crossref
Célia Faustino, Patrícia Rijo & Catarina Pinto Reis. (2017) Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer’s disease. Pharmacological Research 120, pages 68-87.
Crossref
Crossref
Tilman Schuster, Astrid Mühlstein, Claudia Yaghootfam, Olga Maksimenko, Elena Shipulo, Svetlana Gelperina, Jörg Kreuter, Volkmar Gieselmann & Ulrich Matzner. (2017) Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A. Journal of Controlled Release 253, pages 1-10.
Crossref
Crossref
Chad Curtis, Mengying Zhang, Rick Liao, Thomas Wood & Elizabeth Nance. (2016) Systems‐level thinking for nanoparticle‐mediated therapeutic delivery to neurological diseases. WIREs Nanomedicine and Nanobiotechnology 9:2.
Crossref
Crossref
Dimple Sethi Chopra. 2017. Pharmaceutical Sciences. Pharmaceutical Sciences
229
245
.
Dimple Sethi Chopra. 2017. Advancing Medicine through Nanotechnology and Nanomechanics Applications. Advancing Medicine through Nanotechnology and Nanomechanics Applications
118
139
.
Serge Mignani, Maria Bryszewska, Maria Zablocka, Barbara Klajnert-Maculewicz, Josep Cladera, Dzmitry Shcharbin & Jean-Pierre Majoral. (2017) Can dendrimer based nanoparticles fight neurodegenerative diseases? Current situation versus other established approaches. Progress in Polymer Science 64, pages 23-51.
Crossref
Crossref
Y. Liu & Q. He. 2017. Neurotoxicity of Nanomaterials and Nanomedicine. Neurotoxicity of Nanomaterials and Nanomedicine
33
57
.
A. Gaudin, Y.-E. Seo, E. Song, E. Quijano, A.R. King & W.M. Saltzman. 2017. Comprehensive Biomaterials II. Comprehensive Biomaterials II
549
570
.
Anil Kumar Kalvala, Priyanka Giri, Jyothirmai Kaligatla, Wahid Khan & Ashutosh Kumar. 2017. Advances in Personalized Nanotherapeutics. Advances in Personalized Nanotherapeutics
157
185
.
Sara Hernando, Enara Herran, Jose Luis Pedraz, Manoli Igartua & Rosa Maria Hernandez. 2017. Drug and Gene Delivery to the Central Nervous System for Neuroprotection. Drug and Gene Delivery to the Central Nervous System for Neuroprotection
57
87
.
Priyanka Prathipati, Jing Zhu & Xiaowei Dong. (2016) Development of novel HDL-mimicking α-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution. European Journal of Pharmaceutics and Biopharmaceutics 108, pages 126-135.
Crossref
Crossref
Liang Yu, Xiaoke Ma, Long Zhang, Jing Zhang & Lin Gao. (2016) Prediction of new drug indications based on clinical data and network modularity. Scientific Reports 6:1.
Crossref
Crossref
Shringika Soni, Rakesh Kumar Ruhela & Bikash Medhi. (2016) Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective. Advanced Pharmaceutical Bulletin 6:3, pages 319-335.
Crossref
Crossref
C. Ingallina, F. Rinaldi, A. Bogni, J. Ponti, D. Passeri, M. Reggente, M. Rossi, A. Kinsner-Ovaskainen, D. Mehn, F. Rossi, B. Botta, M. Carafa & C. Marianecci. (2016) Niosomal approach to brain delivery: Development, characterization and in vitro toxicological studies. International Journal of Pharmaceutics 511:2, pages 969-982.
Crossref
Crossref
Cláudia Saraiva, Catarina Praça, Raquel Ferreira, Tiago Santos, Lino Ferreira & Liliana Bernardino. (2016) Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases. Journal of Controlled Release 235, pages 34-47.
Crossref
Crossref
Darya Hadavi & André A. Poot. (2016) Biomaterials for the Treatment of Alzheimer’s Disease. Frontiers in Bioengineering and Biotechnology 4.
Crossref
Crossref
Sara Hernando, Oihane Gartziandia, Enara Herran, Jose Luis Pedraz, Manoli Igartua & Rosa Maria Hernandez. (2016) Advances in nanomedicine for the treatment of Alzheimer’s and Parkinson’s diseases. Nanomedicine 11:10, pages 1267-1285.
Crossref
Crossref
Mª Holgado, José Venero, Josefa Fuentes, Mercedes -Arévalo & Lucía Banderas. 2016. Nanotechnology and Drug Delivery, Volume Two. Nanotechnology and Drug Delivery, Volume Two
204
227
.
Chenyu Chu, Jia Deng, Li Liu, Yubin Cao, Xiawei Wei, Jidong Li & Yi Man. (2016) Nanoparticles combined with growth factors: recent progress and applications. RSC Advances 6:93, pages 90856-90872.
Crossref
Crossref
S. A. Papadimitriou, M. P. Robin, D. Ceric, R. K. O'Reilly, S. Marino & M. Resmini. (2016) Fluorescent polymeric nanovehicles for neural stem cell modulation. Nanoscale 8:39, pages 17340-17349.
Crossref
Crossref
Oihane Gartziandia, Enara Herran, Jose Luis Pedraz, Manoli Igartua & Rosa Maria Hernandez. 2016. Nanobiomaterials in Drug Delivery. Nanobiomaterials in Drug Delivery
371
402
.
Palazzo Claudio, Karim Reatul, Evrard Brigitte & Piel Geraldine. 2016. Nanobiomaterials in Drug Delivery. Nanobiomaterials in Drug Delivery
333
370
.
David Stepensky. 2016. Nanomedicine. Nanomedicine
201
220
.
Gert Fricker & Anne Mahringer. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
16
.
I. M. Carvalho, P. B. Coelho, P. C. Costa, C. S. Marques, R. S. Oliveira & D. C. Ferreira. (2015) Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders. NeuroMolecular Medicine 17:4, pages 404-422.
Crossref
Crossref
Dong Hyun Jo, Jin Hyoung Kim, Tae Geol Lee & Jeong Hun Kim. (2015) Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases. Nanomedicine: Nanotechnology, Biology and Medicine 11:7, pages 1603-1611.
Crossref
Crossref
Stephen Meairs. (2015) Facilitation of Drug Transport across the Blood–Brain Barrier with Ultrasound and Microbubbles. Pharmaceutics 7:3, pages 275-293.
Crossref
Crossref
Marc-Antoine Lauzon, Alex Daviau, Bernard Marcos & Nathalie Faucheux. (2015) Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease. Journal of Controlled Release 206, pages 187-205.
Crossref
Crossref
Howard E. Gendelman, Vellareddy Anantharam, Tatiana Bronich, Shivani Ghaisas, Huajun Jin, Anumantha G. Kanthasamy, Xinming Liu, JoEllyn McMillan, R. Lee Mosley, Balaji Narasimhan & Surya K. Mallapragada. (2015) Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases. Nanomedicine: Nanotechnology, Biology and Medicine 11:3, pages 751-767.
Crossref
Crossref
Zhi-Ran Xu, Wu-Fang Wang, Xin-Fang Liang, Ze-Hua Liu, Yu Liu, Liang Lin & Xuan Zhu. (2014) Protective Effects of Poly (butyl) Cyanoacrylate Nanoparticles Containing Vasoactive Intestinal Peptide Against 6-Hydroxydopamine-Induced Neurotoxicity In Vitro. Journal of Molecular Neuroscience 55:4, pages 854-864.
Crossref
Crossref
Laura Ravani, Maria Grazia Sarpietro, Elisabetta Esposito, Antonio Di Stefano, Piera Sozio, Mariangela Calcagno, Markus Drechsler, Catia Contado, Francesco Longo, Maria Chiara Giuffrida, Francesco Castelli, Michele Morari & Rita Cortesi. (2015) Lipid nanocarriers containing a levodopa prodrug with potential antiparkinsonian activity. Materials Science and Engineering: C 48, pages 294-300.
Crossref
Crossref
Christian Wischke, Judith Weigel & Andreas Lendlein. (2015)
Poly(
n
-butylcyanoacrylate) Nanoparticles as Carriers for Adenosine triphosphate
. MRS Proceedings 1718, pages 131-136.
Crossref
Crossref
Marise Kolter, Melanie Ott, Christian Hauer, Isolde Reimold & Gert Fricker. (2015) Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood–brain barrier, in human whole blood and in vivo. Journal of Controlled Release 197, pages 165-179.
Crossref
Crossref
Chandraiah Godugu, Raman Preet Singh & Ramarao Poduri. 2015. Targeted Drug Delivery : Concepts and Design. Targeted Drug Delivery : Concepts and Design
733
781
.
Xiang Yi, Devika S. Manickam, Anna Brynskikh & Alexander V. Kabanov. (2014) Agile delivery of protein therapeutics to CNS. Journal of Controlled Release 190, pages 637-663.
Crossref
Crossref
Jörg Kreuter. (2014) Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?. Advanced Drug Delivery Reviews 71, pages 2-14.
Crossref
Crossref
Meir Goldsmith, Lilach Abramovitz & Dan Peer. (2014) Precision Nanomedicine in Neurodegenerative Diseases. ACS Nano 8:3, pages 1958-1965.
Crossref
Crossref
Shaoling Wu, Guoqi Li, Xiao Li, Caina Lin, Ding Yu, Shuo Luan & Chao Ma. (2014) Transport of Glial Cell Line-Derived Neurotrophic Factor into Liposomes across the Blood-Brain Barrier: In Vitro and in Vivo Studies. International Journal of Molecular Sciences 15:3, pages 3612-3623.
Crossref
Crossref
Yung-Chih Kuo & Cheng-Chin Wang. 2014. Colloid and Interface Science in Pharmaceutical Research and Development. Colloid and Interface Science in Pharmaceutical Research and Development
389
410
.
JOHN N. BARRY & ALEXEY A. VERTEGEL. (2014) NANOMATERIALS FOR PROTEIN-MEDIATED THERAPY AND DELIVERY. Nano LIFE 03:04, pages 1343001.
Crossref
Crossref
V. Yu. Balaban’yan, A. M. Ul’yanov, O. S. Elizarova, I. N. Solev, S. A. Litvinova, T. L. Garibova & T. A. Voronina. (2014) Targeted transport of low-sialylated recombinant human erythropoietin by polymer nanoparticles through the blood-brain barrier. Russian Journal of General Chemistry 83:12, pages 2571-2577.
Crossref
Crossref
Angelina Angelova, Borislav Angelov, Markus Drechsler & Sylviane Lesieur. (2013) Neurotrophin delivery using nanotechnology. Drug Discovery Today 18:23-24, pages 1263-1271.
Crossref
Crossref
E. Garbayo, E. Ansorena & M.J. Blanco-Prieto. (2013) Drug development in Parkinson's disease: From emerging molecules to innovative drug delivery systems. Maturitas 76:3, pages 272-278.
Crossref
Crossref
Lindsay A. Hohsfield, Stephan Geley, Markus Reindl & Christian Humpel. (2013) The generation of NGF-secreting primary rat monocytes: A comparison of different transfer methods. Journal of Immunological Methods 391:1-2, pages 112-124.
Crossref
Crossref
Abhay K. Varma, Arabinda Das, Gerald WallaceIVIV, John Barry, Alexey A. Vertegel, Swapan K. Ray & Naren L. Banik. (2013) Spinal Cord Injury: A Review of Current Therapy, Future Treatments, and Basic Science Frontiers. Neurochemical Research 38:5, pages 895-905.
Crossref
Crossref
Claire Géral, Angelina Angelova & Sylviane Lesieur. (2013) From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF). Pharmaceutics 5:4, pages 127-167.
Crossref
Crossref
Chen Jiang, Xinguo Jiang, Yang Liu, Kun Shao & Rongqin Huang. 2013. Microspheres and Microcapsules in Biotechnology. Microspheres and Microcapsules in Biotechnology
399
464
.
Jae Ho Lee, Jeong-Hui Park, Mohamed Eltohamy, Roman Perez, Eun-Jung Lee & Hae-Won Kim. (2013) Collagen gel combined with mesoporous nanoparticles loading nerve growth factor as a feasible therapeutic three-dimensional depot for neural tissue engineering. RSC Advances 3:46, pages 24202.
Crossref
Crossref
O. S. Elizarova, V. Yu. Balaban’yan, E. V. Shipulo, O. O. Maksimenko, L. V. Vanchugova, S. A. Litvinova, T. L. Garibova, T. A. Voronina & S. É. Gel’perina. (2013) Efficacy of a new colloidal form of low-sialylated polylactide-based erythropoietin in experimental hemorrhagic stroke in rats. Pharmaceutical Chemistry Journal 46:10, pages 626-629.
Crossref
Crossref
Stephen Meairs. 2014. The Blood Brain Barrier (BBB). The Blood Brain Barrier (BBB)
143
158
.
Glen J. Weiss, Manuel Hidalgo, Mitesh J. Borad, Daniel Laheru, Raoul Tibes, Ramesh K. Ramanathan, Lisa Blaydorn, Gayle Jameson, Antonio Jimeno, Jeffrey D. Isaacs, Angela Scaburri, Maria Adele Pacciarini, Francesco Fiorentini, Marina Ciomei & Daniel D. Von Hoff. (2011) Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies. Investigational New Drugs 30:6, pages 2334-2343.
Crossref
Crossref
Aikaterini Lalatsa, Andreas G. Schätzlein & Ijeoma F. Uchegbu*. 2012. Nanostructured Biomaterials for Overcoming Biological Barriers. Nanostructured Biomaterials for Overcoming Biological Barriers
329
363
.
Mariacristina GagliardiGiuseppe Bardi & Angelo Bifone. (2012) Polymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNS. Therapeutic Delivery 3:7, pages 875-887.
Crossref
Crossref
Antonio Nunes, Khuloud T. Al-Jamal & Kostas Kostarelos. (2012) Therapeutics, imaging and toxicity of nanomaterials in the central nervous system. Journal of Controlled Release 161:2, pages 290-306.
Crossref
Crossref
Stefanie Wohlfart, Svetlana Gelperina & Jörg Kreuter. (2012) Transport of drugs across the blood–brain barrier by nanoparticles. Journal of Controlled Release 161:2, pages 264-273.
Crossref
Crossref
Luca Costantino & Diana Boraschi. (2012) Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?. Drug Discovery Today 17:7-8, pages 367-378.
Crossref
Crossref
Blanka Halamoda Kenzaoui, Catherine Chapuis Bernasconi, Heinrich Hofmann & Lucienne Juillerat-Jeanneret. (2012) Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. Nanomedicine 7:1, pages 39-53.
Crossref
Crossref
Vandana Patravale, Prajakta Dandekar & Ratnesh Jain. 2012. Nanoparticulate Drug Delivery. Nanoparticulate Drug Delivery
1
28
.
B. Ruozi, D. Belletti, L. Bondioli, A. De Vita, F. Forni, M.A. Vandelli & G. Tosi. 2012. New Perspectives of Central Nervous System Injury and Neuroprotection. New Perspectives of Central Nervous System Injury and Neuroprotection
207
247
.
Carmen Giordano, Diego Albani, Antonio Gloria, Marta Tunesi, Serena Rodilossi, Teresa Russo, Gianluigi Forloni, Luigi Ambrosio & Alberto Cigada. (2011) Nanocomposites for Neurodegenerative Diseases: Hydrogel-Nanoparticle Combinations for a Challenging Drug Delivery. The International Journal of Artificial Organs 34:12, pages 1115-1127.
Crossref
Crossref
Barbara Pavan, Guglielmo Paganetto & Alessandro Dalpiaz. (2011) Dopamine-sensitive adenylyl cyclases in neuronal development: physiopathological and pharmacological implications. Drug Discovery Today 16:11-12, pages 520-529.
Crossref
Crossref
Inge van Rooy, Serpil Cakir-Tascioglu, Wim E. Hennink, Gert Storm, Raymond M. Schiffelers & Enrico Mastrobattista. (2010) In Vivo Methods to Study Uptake of Nanoparticles into the Brain. Pharmaceutical Research 28:3, pages 456-471.
Crossref
Crossref
Sanju Dhawan, Rishi Kapil & Bhupinder Singh. (2011) Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. Journal of Pharmacy and Pharmacology 63:3, pages 342-351.
Crossref
Crossref
Vladimir Reukov, Victor Maximov & Alexey Vertegel. (2011) Proteins conjugated to poly(butyl cyanoacrylate) nanoparticles as potential neuroprotective agents. Biotechnology and Bioengineering 108:2, pages 243-252.
Crossref
Crossref
Julien Nicolas & Christine Vauthier. 2011. Intracellular Delivery. Intracellular Delivery
225
250
.
Erin Lavik. 2011. Biomaterials for Tissue Engineering Applications. Biomaterials for Tissue Engineering Applications
489
510
.
Luca Costantino. (2010) Drug delivery to the CNS and polymeric nanoparticulate carriers. Future Medicinal Chemistry 2:11, pages 1681-1701.
Crossref
Crossref
Reinhard Gabathuler. (2010) Development of new peptide vectors for the transport of therapeutic across the blood–brain barrier. Therapeutic Delivery 1:4, pages 571-586.
Crossref
Crossref
Hu Yang. (2010) Nanoparticle-Mediated Brain-Specific Drug Delivery, Imaging, and Diagnosis. Pharmaceutical Research 27:9, pages 1759-1771.
Crossref
Crossref
Hari Shanker SharmaAruna Sharma. (2010) Conference Scene: Nanoneuroprotection and nanoneurotoxicity: recent progress and future perspectives. Nanomedicine 5:4, pages 533-537.
Crossref
Crossref